Cafepharma Today

Sarepta sells FDA priority review voucher to Gilead Sciences, did Biogen shoot itself in the foot, Pfizer lands quick review for inotuzumab antibody, and more - scroll down for the latest news

click here for the latest message board posts
click here for the latest on pharma/biotech social media
click here for the latest on device social media

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

Yahoo/Reuters
Tuesday, February 21, 2017 - 11:13am
Motley Fool
Tuesday, February 21, 2017 - 11:11am
Bizjournals.com
Tuesday, February 21, 2017 - 11:10am
Market Realist
Tuesday, February 21, 2017 - 11:09am
Stat
Monday, February 20, 2017 - 11:31am
FDA Law Blog
Monday, February 20, 2017 - 10:07am
Motley Fool
Monday, February 20, 2017 - 9:55am
Market Realist
Monday, February 20, 2017 - 9:54am
Fierce Biotech
Sunday, February 19, 2017 - 12:16pm
Market Realist
Sunday, February 19, 2017 - 12:13pm
tags:
Mass Device
Saturday, February 18, 2017 - 2:39pm
Yahoo/Reuters
Saturday, February 18, 2017 - 2:35pm
TheStreet.com
Friday, February 17, 2017 - 11:04am
TheStreet.com
Friday, February 17, 2017 - 11:02am
Bizjournals.com
Friday, February 17, 2017 - 10:14am
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.